These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8425535)

  • 1. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
    Otvos L; Szendrei GI; Lee VM; Mantsch HH
    Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    Eur J Biochem; 1991 Oct; 201(1):61-9. PubMed ID: 1915378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
    Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
    J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro.
    Fabian H; Szendrei GI; Mantsch HH; Greenberg BD; Otvös L
    Eur J Biochem; 1994 May; 221(3):959-64. PubMed ID: 8181478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein.
    Fraser PE; Nguyen JT; Inouye H; Surewicz WK; Selkoe DJ; Podlisny MB; Kirschner DA
    Biochemistry; 1992 Nov; 31(44):10716-23. PubMed ID: 1420187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
    Wood SJ; Wetzel R; Martin JD; Hurle MR
    Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism.
    Fabian H; Szendrei GI; Mantsch HH; Otvos L
    Biochem Biophys Res Commun; 1993 Feb; 191(1):232-9. PubMed ID: 8447825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1992 Nov; 228(2):460-73. PubMed ID: 1453457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
    Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
    J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.
    Barrow CJ; Zagorski MG
    Science; 1991 Jul; 253(5016):179-82. PubMed ID: 1853202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-dependent structural transitions of Alzheimer amyloid peptides.
    Fraser PE; Nguyen JT; Surewicz WK; Kirschner DA
    Biophys J; 1991 Nov; 60(5):1190-201. PubMed ID: 1760507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.
    Inouye H; Fraser PE; Kirschner DA
    Biophys J; 1993 Feb; 64(2):502-19. PubMed ID: 8457674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
    Zagorski MG; Barrow CJ
    Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates.
    Fasman GD; Perczel A; Moore CD
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):369-71. PubMed ID: 7831292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
    Shao H; Jao S; Ma K; Zagorski MG
    J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of aggregation of synthetic beta-amyloid peptide.
    Tomski SJ; Murphy RM
    Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
    Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
    Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB.
    Jarrett JT; Lansbury PT
    Biochemistry; 1992 Dec; 31(49):12345-52. PubMed ID: 1463722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.